UR1 THERAPEUTICS Trademark

Trademark Overview

On Tuesday, December 7, 2021, a trademark application was filed for UR1 THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the UR1 THERAPEUTICS trademark a serial number of 97159322. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, April 13, 2023. This trademark is owned by FBIO Acquisition Corp. VIII. The UR1 THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for human use for the treatment of inflammatory disease, joint disorder, inflammatory arthritis, and gout; Pharmaceutical preparations for human use for the treatment of hyperuricemia and tophaceous gout; Pharmaceutical preparations for human use for the treatment of inflammatory disorders

Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines for the treatment of inflammatory disease, joint disorder, inflammatory arthritis, and gout; Scientific research for medical purposes in the field of inflammatory disease, joint disorder, inflammatory arthritis, and gout; Scientific research for medical purposes in the field of diseases and disorders where hyperuricemia is present; Scientific research for medical purposes in the field of inflammatory disorders; Scientific research for medical purposes in the fields of hyperuricemia and tophaceous gout
ur1 therapeutics

General Information

Serial Number97159322
Word MarkUR1 THERAPEUTICS
Filing DateTuesday, December 7, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, April 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of inflammatory disease, joint disorder, inflammatory arthritis, and gout; Pharmaceutical preparations for human use for the treatment of hyperuricemia and tophaceous gout; Pharmaceutical preparations for human use for the treatment of inflammatory disorders
Pseudo MarkUR ONE THERAPEUTICS
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines for the treatment of inflammatory disease, joint disorder, inflammatory arthritis, and gout; Scientific research for medical purposes in the field of inflammatory disease, joint disorder, inflammatory arthritis, and gout; Scientific research for medical purposes in the field of diseases and disorders where hyperuricemia is present; Scientific research for medical purposes in the field of inflammatory disorders; Scientific research for medical purposes in the fields of hyperuricemia and tophaceous gout

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFBIO Acquisition Corp. VIII
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events

Event DateEvent Description
Friday, April 14, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, April 13, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, April 13, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, September 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 16, 2022NON-FINAL ACTION E-MAILED
Friday, September 16, 2022NON-FINAL ACTION WRITTEN
Thursday, September 15, 2022ASSIGNED TO EXAMINER
Monday, December 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 10, 2021NEW APPLICATION ENTERED

Related Keywords

therapeutics inflammatory pharmaceutical research medical gout preparations scientific purposes treatment human